| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447037 | European Journal of Cancer | 2011 | 9 Pages |
Abstract
The results of the present study show that systemic inflammation-based scores, in particular the mGPS and PI, have prognostic value in cancer independent of tumour site. Based on the present results and the existing validation literature, the mGPS should be included in the routine assessment of all patients with cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Michael J. Proctor, David S. Morrison, Dinesh Talwar, Steven M. Balmer, Colin D. Fletcher, Denis St.J. O'Reilly, Alan K. Foulis, Paul G. Horgan, Donald C. McMillan,